YU32178A - Process for obtaiing quinazoline compounds - Google Patents

Process for obtaiing quinazoline compounds

Info

Publication number
YU32178A
YU32178A YU00321/78A YU32178A YU32178A YU 32178 A YU32178 A YU 32178A YU 00321/78 A YU00321/78 A YU 00321/78A YU 32178 A YU32178 A YU 32178A YU 32178 A YU32178 A YU 32178A
Authority
YU
Yugoslavia
Prior art keywords
obtaiing
quinazoline compounds
quinazoline
compounds
obtaiing quinazoline
Prior art date
Application number
YU00321/78A
Other languages
English (en)
Inventor
R R Grenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU32178A publication Critical patent/YU32178A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU00321/78A 1977-02-22 1978-02-13 Process for obtaiing quinazoline compounds YU32178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,966 US4101548A (en) 1977-02-22 1977-02-22 1,2,3-Thiadiazole amides

Publications (1)

Publication Number Publication Date
YU32178A true YU32178A (en) 1983-01-21

Family

ID=25090261

Family Applications (4)

Application Number Title Priority Date Filing Date
YU00321/78A YU32178A (en) 1977-02-22 1978-02-13 Process for obtaiing quinazoline compounds
YU01982/82A YU198282A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds
YU01984/82A YU198482A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds
YU01983/82A YU198382A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds

Family Applications After (3)

Application Number Title Priority Date Filing Date
YU01982/82A YU198282A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds
YU01984/82A YU198482A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds
YU01983/82A YU198382A (en) 1977-02-22 1982-09-02 Process for obtaining quinazoline compounds

Country Status (19)

Country Link
US (1) US4101548A (fr)
JP (1) JPS53103485A (fr)
AU (1) AU518108B2 (fr)
BE (1) BE864095A (fr)
CA (1) CA1121820A (fr)
CH (1) CH634318A5 (fr)
DE (1) DE2807392A1 (fr)
DK (1) DK75178A (fr)
FI (1) FI780566A (fr)
FR (1) FR2381046A1 (fr)
GB (1) GB1586556A (fr)
GR (1) GR67024B (fr)
IE (1) IE46652B1 (fr)
IT (1) IT1105287B (fr)
LU (1) LU79087A1 (fr)
NL (1) NL7801996A (fr)
SE (1) SE7802022L (fr)
YU (4) YU32178A (fr)
ZA (1) ZA78992B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2728523C2 (de) * 1977-06-23 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen 4-Methyl-1,2,3-thiadiazol-5-carbonsäure-(cyclohexylmethyl)-amid, Mittel mit herbizider und wachstumsregulatorischer Wirkung enthaltend diese Verbindung sowie Verfahren zu seiner Herstellung
US4309541A (en) * 1978-09-20 1982-01-05 Ciba-Geigy Corporation Piperidinyl-lactams
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4377581A (en) * 1980-03-03 1983-03-22 Pfizer Inc. Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
US4351940A (en) * 1980-03-03 1982-09-28 Pfizer Inc. Chloro- and alkoxy-substituted-2-chloro-4-aminodquinazolines
JPS5791987A (en) * 1980-11-26 1982-06-08 Sankyo Co Ltd Aminoquinazoline derivative and its preparation
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5696159A (en) * 1994-08-03 1997-12-09 Cell Pathways, Inc. Lactone compounds for treating patients with precancerous lesions
US5776962A (en) * 1994-08-03 1998-07-07 Cell Pathways, Inc. Lactone compounds for treating patient with precancerous lesions
US6232312B1 (en) 1995-06-07 2001-05-15 Cell Pathways, Inc. Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
US6046216A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
US6262059B1 (en) 1995-06-07 2001-07-17 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with quinazoline derivatives
US5874440A (en) * 1995-06-07 1999-02-23 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
US6200980B1 (en) 1995-06-07 2001-03-13 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl purinone derivatives
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
CA2232138A1 (fr) * 1995-09-29 1997-04-03 William C. Lumma Antagonistes du recepteur adrenergique alpha 1b
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (fr) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques
US5852035A (en) * 1997-12-12 1998-12-22 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US5942520A (en) * 1998-01-27 1999-08-24 Cell Pathways, Inc. Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines
US5990117A (en) * 1998-04-15 1999-11-23 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
US6180629B1 (en) 1998-08-14 2001-01-30 Cell Pathways, Inc. [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6420400B1 (en) 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
US7893101B2 (en) * 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7276529B2 (en) * 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) * 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7208516B2 (en) * 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
WO2003086373A1 (fr) * 2002-04-12 2003-10-23 Celgene Corporation Techniques d'identification de modulateurs d'angiogenese, composes decouverts par ces techniques et techniques de traitement utilisant ces composes
MXPA04009997A (es) * 2002-04-12 2004-12-13 Celgene Corp Modulacion de la diferenciacion de celulas madre y progenitoras, ensayos y usos de las mismas.
US20070155791A1 (en) * 2005-12-29 2007-07-05 Zeldis Jerome B Methods for treating cutaneous lupus using aminoisoindoline compounds
WO2009120296A1 (fr) * 2008-03-24 2009-10-01 Celgene Corporation Traitement du psoriasis ou du rhumatisme psoriasique par le cyclopropyl-n-{2-{(1s)-1-(3-éthoxy-4-méthoxyphényl)-2-(méthylsulfonyl)éthyl]-3-oxoisoindoline-4-yl}carboxamide
JP6687550B2 (ja) 2014-06-23 2020-04-22 セルジーン コーポレイション 肝疾患又は肝機能異常を治療するためのアプレミラスト

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE942029C (de) * 1951-06-22 1956-04-26 American Cyanamid Co Verfahren zur Herstellung von neuen, in 1-Stellung substituierten 4-Aminopiperazinderivaten
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US3594980A (en) * 1969-10-03 1971-07-27 Charles C Diehl Treating polluted gases in baffle chamber
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
US3780040A (en) * 1972-06-02 1973-12-18 R Schnettler 2-substituted-3,4-dihydroquinazolines
JPS536156B2 (fr) * 1972-10-30 1978-03-04
US4001238A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company 1,3,4-oxadiazole amides
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process

Also Published As

Publication number Publication date
YU198282A (en) 1983-01-21
YU198482A (en) 1983-01-21
IT1105287B (it) 1985-10-28
CH634318A5 (fr) 1983-01-31
SE7802022L (sv) 1978-08-23
GR67024B (fr) 1981-05-20
IE46652B1 (en) 1983-08-10
FR2381046B1 (fr) 1982-11-12
ZA78992B (en) 1979-09-26
GB1586556A (en) 1981-03-18
DK75178A (da) 1978-08-23
DE2807392A1 (de) 1978-08-24
IT7848131A0 (it) 1978-02-21
NL7801996A (nl) 1978-08-24
BE864095A (fr) 1978-08-17
LU79087A1 (fr) 1978-09-28
FI780566A (fi) 1978-08-23
US4101548A (en) 1978-07-18
AU3322478A (en) 1979-08-23
CA1121820A (fr) 1982-04-13
YU198382A (en) 1983-01-21
AU518108B2 (en) 1981-09-17
JPS53103485A (en) 1978-09-08
IE780369L (en) 1978-08-22
FR2381046A1 (fr) 1978-09-15

Similar Documents

Publication Publication Date Title
YU32178A (en) Process for obtaiing quinazoline compounds
YU253678A (en) Process for obtaining cardiostimulating quinazolines
YU213078A (en) Process for obtaining sulfonylamidine compounds
YU42073B (en) Process for obtaining 1-oxadethiaceptham compounds
YU91478A (en) Process for obtaining hexahydro-gamma-carboline compounds
YU250378A (en) Process for obtaining n-cyano-and n-alkinyl-2-(substitutedphenoxy)-butyramids
YU143678A (en) Process for obtaining substituted cyclopropylmethoxyanilides
YU137578A (en) Process for obtaining mercaptoacyl-aminobenzoylglycine
PT67821A (en) Process for preparing quinazoline derivatives
YU39417B (en) Process for obtaining auranophine
YU300377A (en) Process for obtaining 4-amino-epimeric oleandomycins
GB2003475B (en) Process for 2-chlorosulphinylazetidin-4-ones
YU42089B (en) Process for obtaining substituted 2-cyclopropyl-chromones
YU71178A (en) Process for obtaining 2-hydroxybenzothiazole compounds
YU160978A (en) Process for obtaining tetrahydro-s-triazine-thione
YU40674B (en) Process for obtaining di-n-propylacetonitrile
YU54783A (en) Process for obtaining 1-oxadethiacepham compounds
JPS53130670A (en) Substituted pireridivulpropanol derivtive related compounds and process for preparing same
YU40675B (en) Process for obtaining di-n-propyl-acetamide
YU65979A (en) Process for obtaining quinazoline
YU233278A (en) Process for obtaining quinazoline
YU54983A (en) Process for obtaining 1-oxadethiacepham compounds
JPS53116362A (en) Process for 16alphaamethylsteroid
IL54182A0 (en) Process for 3-beta-aminoazetiden-2-ones
YU297678A (en) Process for obtaining new 2-aryl-1h-pyrimidine compounds